Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Electroceuticals: Drug-Like Effects, Without The Drugs

This article was originally published in Start Up

Executive Summary

Electroceuticals could replace the use of pharmaceuticals in many chronic diseases, offering effective treatments without, perhaps, side effects. Medtechs pioneering these next-gen neuromodulation devices are sparking investor interest.


Related Content

US Approvals Analysis: April A Big Month For Non-Invasive Neurostim
New-Gen Devices Offer Sleep Apnea Patients Alternative CPAP Routes
Neuromodulation Start-Ups: Abundant Funding, Slow Exits
GSK Venture Fund Selects Neurostim Device Maker SetPoint Medical As First Investment
electroCore Aims Noninvasive Neurostimulation At The Masses
GSK Ventures Into The Device World Through Bioelectronic Investment
Emerging Peripheral Nerve Technologies Draw New Competitors To Neuromodulation Market
With Academic Collaborators, GSK To Plug For ‘Electroceuticals’


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts